Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-21 4:30 pm Purchase | 2024-09-13 | 13D | Clearside Biomedical, Inc. CLSD | Hatteras Venture Advisors IV SBIC, LLC | 313,641 0.400% | 313,641 (New Position) | Filing History |
| 2023-11-01 4:04 pm Purchase | 2023-10-27 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 6,264,964 10.100% | 247,112 (+4.11%) | Filing History |
| 2023-02-14 10:29 am Sale | 2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW Investments, LP | 0 0.000% | -3,806,018 (Position Closed) | Filing History |
| 2023-02-13 12:19 pm Sale | 2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD | Carmignac Gestion | 2,400,344 3.980% | -723,908 (-23.17%) | Filing History |
| 2023-01-04 4:15 pm Sale | 2022-12-15 | 13D | Clearside Biomedical, Inc. CLSD | Hatteras Venture Advisors III LLC | 3,654,062 6.100% | -1,360,858 (-27.14%) | Filing History |
| 2023-01-04 12:06 pm Purchase | 2022-12-31 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 6,017,852 9.900% | 139,655 (+2.38%) | Filing History |
| 2022-02-14 08:44 am Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW Investments, LP | 3,806,018 6.400% | -152,112 (-3.84%) | Filing History |
| 2022-02-09 2:09 pm Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | Carmignac Gestion | 3,124,252 5.200% | -416,709 (-11.77%) | Filing History |
| 2022-01-24 4:03 pm Sale | 2021-12-31 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 5,878,197 9.900% | -486,989 (-7.65%) | Filing History |
| 2021-02-12 12:25 pm Purchase | 2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD | Carmignac Gestion | 3,540,961 7.300% | 3,540,961 (New Position) | Filing History |
| 2021-02-12 09:55 am Purchase | 2020-12-31 | 13G | Clearside Biomedical, Inc. CLSD | RTW Investments, LP | 3,958,130 8.190% | 208,023 (+5.55%) | Filing History |
| 2021-01-07 11:10 am Purchase | 2021-01-06 | 13G | Clearside Biomedical, Inc. CLSD | WHITMORE BRADFORD T | 6,365,186 11.100% | 929,845 (+17.11%) | Filing History |